Optimal therapy for oesophageal cancer
- 1 August 2003
- journal article
- review article
- Published by Elsevier in Cancer Treatment Reviews
- Vol. 29 (4) , 275-282
- https://doi.org/10.1016/s0305-7372(02)00131-7
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- 5-Fluorouracil and cisplatin as palliative treatment of advanced oesophageal squamous cell carcinomaBritish Journal of Surgery, 2003
- Three-Field Lymph Node Dissection for Squamous Cell and Adenocarcinoma of the EsophagusAnnals of Surgery, 2002
- Cancer Statistics, 2002CA: A Cancer Journal for Clinicians, 2002
- CLINICAL UNDER STAGING OF HIGH RISK NONMUSCLE INVASIVE UROTHELIAL CARCINOMA TREATED WITH RADICAL CYSTECTOMYJournal of Urology, 2001
- Chemotherapy of Esophageal CarcinomaOncology Research and Treatment, 1999
- 1180: First demonstration of anti-lymphoma activity of BCL-2 antisense molecule-G3139; Results of phase I/IIA clinical trialEuropean Journal Of Cancer, 1997
- Carcinoma of the oesophagus: The time for a multidiciplinary approach?Surgical Oncology, 1996
- Squamous oesophageal cancer can be downstaged using protracted venous infusion of 5-fluorouracil with epirubicin and cisplatin (ECF)European Journal Of Cancer, 1995
- Chemoradiation: A superior alternative for the primary management of esophageal carcinomaSeminars in Radiation Oncology, 1994
- Pre‐operative radiotherapy prolongs survival in operable esophageal carcinoma: A randomized, multicenter study of pre‐operative radiotherapy and chemotherapy. The second scandinavian trial in esophageal cancerWorld Journal of Surgery, 1992